Render Target: STATIC
Render Timestamp: 2024-11-21T12:54:23.477Z
Commit: 5c4accf06eb7154018ba3f54329c7590f97f534a
XML generation date: 2024-08-29 19:55:39.067
Product last modified at: 2024-09-05T15:15:07.548Z
1% for the planet logo
PDP - Template Name: Growth Factors and Cytokines
PDP - Template ID: *******9ad1159

Human IFN-α1 Recombinant Protein #80435

    Product Information

    Storage

    Human IFN-α1 Recombinant Protein is supplied as a lyophilized material that is very stable at -20ºC. It is recommended to reconstitute with sterile water at a concentration of 0.1 mg/mL which can be further diluted in aqueous solutions as needed. Addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage.

    Once in solution, store at 4ºC and use within 1 month, or store at -20ºC to -80ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles if storing reconstituted material at -20ºC to -80ºC.

    Product Description

    MW (kDa) 17-20
    Purity A greater than or equal to 95% purity was determined by SDS-PAGE.
    Endotoxin Endotoxin levels are less than or equal to 1 EU/ 1 μg hIFN-α1.
    Activity The bioactivity of recombinant IFN-α1 was determined in a TF-1 human erythroleukemic cell proliferation assay. The ED50 for this effect is 0.327 ng/mL.

    Source / Purification

    Recombinant human IFN-α1 was expressed in 293 cells with a C-terminal His-tag and is supplied in a lyophilized form.

    Background

    Interferon-α1 is a member of the type I interferon (IFN) (1) family best known for their antiviral activity. Most nucleated cells produce one or more type I IFNs in response to viral infection (2). Secreted type I IFN then induces viral protective responses in neighboring non-infected cells. Type I IFNs also enhance virus-induced apoptosis (3). Other IFN-α1 activities include enhancement of dendritic cell maturation and cytotoxic T cell activity (4). IFN-α1 binds to the IFN-αR1 and IFN-αR2 heterodimer (1). Intracellular signaling through the Jak/Stat pathway is best characterized (3). However, the PI3K, ERK, and p38 kinase pathways are also involved (5). The antiviral activities of the IFNs have led to their use in treating viral infections (4). Type I IFNs also appear to have an integral role in several autoimmune diseases (6).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.